News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,982 Results
Type
Article (86727)
Company Profile (703)
Press Release (763550)
Multimedia
Podcasts (138)
Webinars (18)
Section
Business (232770)
Career Advice (4130)
Deals (39746)
Drug Delivery (129)
Drug Development (91060)
Employer Resources (198)
FDA (18155)
Job Trends (17353)
News (396697)
Policy (39794)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (103)
Alliances (56935)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (186)
Approvals (18104)
Artificial intelligence (368)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (374)
Cancer (2899)
Cardiovascular disease (233)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (35)
Cell therapy (550)
Cervical cancer (23)
Clinical research (74010)
Collaboration (1038)
Company closure (3)
Compensation (650)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (316)
Cystic fibrosis (117)
Data (2869)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (330)
Diagnostics (6960)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (165)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (124)
Earnings (97412)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131243)
Executive appointments (880)
FDA (19754)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (942)
Gene editing (142)
Generative AI (36)
Gene therapy (416)
GLP-1 (897)
Government (5226)
Grass and pollen (6)
Guidances (180)
Healthcare (20911)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (8)
Indications (37)
Infectious disease (3070)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (115)
Interviews (813)
IPO (17885)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10128)
Liver cancer (83)
Lung cancer (412)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (408)
MASH (92)
Medical device (14691)
Medtech (14696)
Mergers & acquisitions (22530)
Metabolic disorders (879)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (38)
Neuroscience (2245)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (46)
Obesity (465)
Opinion (285)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (112)
Parkinson's disease (190)
Partnered (25)
Patents (293)
Patient recruitment (142)
Peanut (54)
People (65581)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22855)
Phase II (32136)
Phase III (24196)
Pipeline (1601)
Policy (217)
Postmarket research (3552)
Preclinical (10317)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (493)
Real estate (7397)
Recruiting (75)
Regulatory (27004)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (159)
Series B (106)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (88)
Vaccines (876)
Venture capitalists (51)
Weight loss (316)
Women's health (48)
Worklife (20)
Date
Today (73)
Last 7 days (552)
Last 30 days (2708)
Last 365 days (34833)
2025 (16521)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50416)
Australia (8864)
California (7446)
Canada (2302)
China (680)
Colorado (319)
Connecticut (337)
Delaware (192)
Europe (115675)
Florida (1102)
Georgia (253)
Hawaii (1)
Idaho (65)
Illinois (709)
India (32)
Indiana (372)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1068)
Massachusetts (5694)
Michigan (268)
Minnesota (464)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2077)
New Mexico (31)
New York (2090)
North Carolina (1210)
North Dakota (10)
Northern California (3214)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1595)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2745)
Tennessee (121)
Texas (1123)
United States (28159)
Utah (221)
Virginia (199)
Washington D.C. (80)
Washington State (659)
West Virginia (4)
Wisconsin (82)
There are 850,982 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
Ventyx’s Parkinson’s Pill Shows ‘Promising’ Results in Mid-Stage Study, Paving Path to Other Neuro Diseases
Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including Alzheimer’s.
June 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Hemostemix Closes Private Placement of $469,366
June 17, 2025
·
6 min read
Mergers & acquisitions
Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical
The pending deal was rumored overnight after a report from the
Financial Times
, spurring analysts to speculate that if true, the entire gene editing space would see a boost at the markets.
June 17, 2025
·
3 min read
·
Annalee Armstrong
Cancer
Roche, AbbVie’s Venclexta Stumbles Again, This Time in Myelodysplastic Syndromes
Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic syndromes.
June 17, 2025
·
1 min read
·
Tristan Manalac
Government
Court Orders Restoration of Canceled NIH Grants, Calls Cuts ‘Appalling’
District Judge William Young, a nominee of Republican President Ronald Reagan, blasted the Trump administration’s NIH cuts as discriminatory and “bearing down on people of color because of their color.”
June 17, 2025
·
2 min read
·
Tristan Manalac
CDC
CDC Scientist Resigns in Protest as Kennedy Reshapes Vaccine Regulation
HHS Secretary Robert F. Kennedy Jr.’s actions in recent months have raised concerns that he is taking a heavy-handed and unilateral approach to vaccine policy in the U.S.
June 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Avata Biosciences Signs Co-Development and Licensing Agreement with Oceanus Bio for Exclusive Rights in Japan and Asia (Excluding China and India) for Novel Adult and Pediatric Oral Cannabidiol Therapies for Development in Epilepsy and Schizophrenia
June 17, 2025
·
3 min read
Press Releases
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
June 17, 2025
·
7 min read
Press Releases
SunRock Biopharma and Escugen Forge Alliance to Develop First-in-Class CCR9-Targeted ADC
June 17, 2025
·
3 min read
Press Releases
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
June 17, 2025
·
12 min read
1 of 85,099
Next
